Skip to main content
    O

    Oragenics Inc (OGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.43
    -0.01 (-3.33%)

    Market Cap: $1.89M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(14/23)
    Avg Surprise
    -16.98%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.57N/AN/ABeat+84.4%
    Mar 26
    Reported May 8
    		$-0.51N/AN/ABeat-91.4%
    Sep 25
    Reported Nov 7
    		$-1.96$0.00N/AMiss-419.5%
    Jun 25
    Reported Aug 8
    		$-3.10$0.00N/AMiss-509.0%
    Mar 25
    Reported May 9
    		$-3.65N/AN/ABeat-420.7%
    Dec 24
    Reported Mar 14
    		$-0.27N/AN/ABeat+93.6%
    Sep 24
    Reported Nov 13
    		$-0.38N/AN/ABeat+55.8%
    Jun 24
    Reported Aug 9
    		$-0.51N/AN/ABeat+66.2%
    Mar 24
    Reported May 15
    		$-0.70N/AN/ABeat+98.3%
    Dec 23
    Reported Mar 29
    		$-4.14$3.00-237.93%Miss-272.7%
    Sep 23
    Reported Nov 9
    		$-0.85$0.00N/ABeat+98.4%
    Jun 23
    Reported Aug 14
    		$-1.51$-3.00+49.78%Beat+97.2%
    Mar 23
    Reported May 12
    		$-42.30N/A+53.01%Beat+53.0%
    Dec 22
    Reported Mar 29
    		$-1.11N/A+53.75%Beat+7.5%
    Sep 22
    Reported Nov 14
    		$-54.01$-90.01+40.00%Beat+25.0%
    Jun 22
    Reported Aug 9
    		$-54.01$-72.01+25.00%Beat+0.0%
    Mar 22
    Reported May 13
    		$-90.01$-36.00-150.03%Miss+0.0%
    Dec 21
    Reported Mar 24
    		$-1.20$-2.40+50.00%Beat+60.0%
    Sep 21
    Reported Nov 15
    		$-72.01$-72.01+0.00%Beat+50.0%
    Jun 21
    Reported Aug 16
    		$-54.01$-72.01+25.00%Beat+87.5%
    Mar 21
    Reported May 3
    		$-90.01$-72.01-25.00%Miss+54.5%
    Dec 20
    Reported Mar 2
    		$-3.00$-3.60+16.67%Beat+37.5%
    Sep 20
    Reported Nov 10
    		$-144.01$-126.01-14.28%Miss+0.0%
    Jun 20
    Reported Aug 14
    		$-432.04$-162.02-166.66%Miss-140.0%
    Mar 20
    Reported May 15
    		$-198.02$-144.01-37.50%Miss+0.0%
    Dec 19
    Reported Mar 4
    		$-4.80$-5.80+17.24%Beat+11.1%
    Sep 19
    Reported Nov 14
    		$-144.01$-189.02+23.81%Beat+77.1%
    Jun 19
    Reported Aug 14
    		$-180.02$-126.01-42.86%Miss+73.7%
    Mar 19
    Reported May 13
    		$-198.02$-153.02-29.41%Miss-47047.6%
    Dec 18
    Reported Mar 29
    		$-5.40$-6.00+10.00%Beat-1700.0%
    Sep 18
    Reported Nov 13
    		$-630.06$-378.04-66.66%Miss-149914.3%
    Jun 18
    Reported Aug 13
    		$-684.07$-810.08+15.56%Beat-341935.0%
    Mar 18
    Reported May 15
    		$-0.42$-0.42+0.00%Beat-5.0%
    Dec 17
    Reported Feb 16
    		$-0.30N/AN/ABeat+40.0%
    Sep 17
    Reported Oct 31
    		$-0.42N/AN/ABeat-
    Jun 17
    Reported Aug 14
    		$-0.20N/AN/ABeat-
    Mar 17
    Reported May 15
    		$-0.40$0.00N/ABeat-
    Dec 16
    Reported Feb 27
    		$-0.50$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-1307.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-563.32x
    Current Ratio3.01xQuick Ratio3.01x
    Trading Statistics
    Beta1.26Avg Volume28.93K
    52-Week High$1.4552-Week Low$0.43

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.47
    SMA 20$0.48
    SMA 50$0.51
    SMA 200$0.63
    EMA 10$0.46
    EMA 20$0.48
    EMA 50$0.50
    EMA 200$0.81

    MACD

    Line: -0.02Signal: -0.01Hist: -0.00

    ADX

    ADX: 16.7+DI: 12.6-DI: 22.4

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down100.0
    PSAR$0.51

    Bollinger Bands

    Upper Band$0.53
    Lower Band$0.43
    %B Position2019%(Upper)
    Band Width-0.01

    RSI (14-Day)

    Neutral
    34.7

    Momentum Oscillators

    Stoch %K3.6
    Stoch %D4.2
    Williams %R-97.9
    ROC (10d)-12.2%
    Momentum-0.06
    CCI (20d)-194.3
    MFI (14d)30.3

    Volatility Measures

    ATR (14d)$0.03(6.1%)
    StdDev (20d)0.02
    Hist Vol65.6%(High)

    Volume Flow

    VWAP$0.44
    OBV237.9M
    AD Line24.9B
    CMF (20d)-0.200

    Volume Metrics

    Avg Vol (20d)27.8K
    Vol Ratio0.6x
    VWMA (20d)$0.48

    Pivot Points

    R3$0.47
    R2$0.46
    R1$0.45
    Pivot Point$0.45
    S1$0.44
    S2$0.43
    S3$0.43

    Advanced Oscillators

    TSI-16.82
    Ultimate Osc29.8
    KST-77.54

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$3.14M$0$0$0$-37,653$7,466
    Cost of Revenue$0$0N/A$0$0$0$1.57M$0$0$0$11.04M$0
    Gross Profit$0$0N/A$0$0$0$1.57M$0$0$0$-11,041,981$7,466
    Operating Expenses$2.59M$2.26M$2.50M$3.12M$1.71M$2.03M$3.36M$2.44M$2.31M$2.46M$12.80M$2.10M
    R&D$1.18M$645,470$670,543$930,894$449,679$341,542$1.67M$879,041$906,779$663,414$11.04M$769,350
    SG&A$1.42M$1.61M$1.83M$2.19M$1.26M$1.68M$1.69M$1.56M$1.40M$1.80M$1.75M$1.33M
    Operating Income$-2,592,528$-2,255,927$-2,498,301$-3,123,773$-1,714,202$-2,026,227$-3,355,432$-2,437,280$-2,306,000$-2,460,103$-12,796,324$-2,094,446
    Interest Income$30,026$40,876$87,091$68,142$16,793$10,203$10,791$9,466$6,405$19,235$38,626$50,613
    Interest Expense$414$3,727$7,454$7,039$572,310$199,127$10,969$9,971$1,803$7,085$0$14,170
    Income Before Tax$-2,575,084$-2,223,868$-2,423,780$-3,066,589$-2,272,035$-2,216,993$-3,349,125$-2,462,870$-2,305,090$-2,450,833$-12,747,429$-2,012,885
    Income Tax Expense$-46,377$-22,625$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,528,707$-2,201,243$-2,286,870$-3,066,589$-2,272,035$-2,216,993$-3,349,125$-2,462,870$-2,305,090$-2,450,833$-12,747,429$-2,012,885
    EBITDA$-2,604,696$-2,261,017$-2,503,417$-3,127,692$-1,137,940$-1,835,210$-3,348,947$-2,462,365$-2,309,692$-2,462,983$-12,773,824$-2,044,543
    EBIT$-2,604,696$-2,261,017$-2,503,417$-3,127,692$-1,716,518$-2,028,069$-3,348,947$-2,462,365$-2,309,692$-2,462,983$-12,773,824$-2,049,328
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OGEN

    News

    Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum

    Oragenics Chief Medical Officer, James P. Kelly, MD, is scheduled to present at the IPAC-RS 2026 Nasal Innovation Forum on September 17, 2026. He will discuss the development and clinical translation of ONP-002...

    Yahoo! Finance Canada•9/16/26•Somewhat-Bullish

    Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update

    Oragenics, Inc. (NYSE American: OGEN) provided updates on its Phase IIa clinical trial for ONP-002, U.S. regulatory pathway...

    The Manila Times•8/28/26•Somewhat-Bearish

    OGEN PE Ratio & Valuation, Is OGEN Overvalued

    Oragenics Inc (OGEN) is currently in the "Fair zone" according to its forward P/S ratio of 0.00, compared to its five-year average of -0.91. The company's current Price-to-Book (P/B) ratio is 0.66...

    Intellectia AI•8/24/26•Neutral

    Oragenics: Q2 Earnings Snapshot

    This article provides a Q2 earnings snapshot for Oragenics. Due to the limited content provided, no further details can be extracted.

    10TV•8/13/26•Neutral

    Oragenics (OGEN) flags going concern risk with $4.7M loss and $3.9M cash

    Oragenics (OGEN) reported a net loss of $4.7 million and had $3.9 million in cash as of June 30, 2026, leading to a "going concern" warning from its auditor and management due to recurring losses and an accumulated...

    Stock Titan•8/13/26•Bearish

    OGEN Valuation and Fair Value

    PEG
    0.0x
    P/B
    0.5x
    See GNG's fair value

    OGEN Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -1307.0%

    OGEN Competitors

    CompanyTicker
    Genprex IncGNPX
    Curis IncCRIS
    Nexgel IncNXGL
    Protagenic TherapeuticsPTIX
    Purple BiotechPPBT
    Iterum Therapeutics PLCITRM
    NewGenIvf Group Limited Class A Ordinary SharesNIVF
    Mobile-health Network Solutions Class A Ordinary SharesMNDR

    Sector: Healthcare

    OGEN Bull Case vs Bear Case

    Bear case

    • OGEN's quarterly revenue changed -91.3% year over year.

    OGEN Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    49.1%

    Frequently Asked Questions About OGEN

    Does OGEN pay dividends?

    Oragenics Inc (OGEN) does not currently pay a regular dividend.

    What is OGEN's market cap?

    Oragenics Inc (OGEN) has a market capitalization of $1.89M with a current stock price of $0.43.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In